Branched chain amino acids in heptatic encephalopathy

American Journal of Surgery

Volumn 183, Issue 4, 2002, Pages 424-429

  James, J Howard ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Branched chain amino acids; Glutamine; Hepatic encephalopathy; Hyperammonemia; Transamination

Indexed keywords

AMINO ACID; AMMONIA; NEUROTRANSMITTER;

AMINO ACID BRAIN LEVEL; AMINO ACID TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; CELL ENERGY; CHRONIC LIVER DISEASE; CITRIC ACID CYCLE; ENERGY YIELD; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; METABOLISM; MOLECULAR INTERACTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEM L; AMINO ACIDS, BRANCHED-CHAIN; AMMONIA; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DOPAMINE; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; SEROTONIN;

EID: 0036227771     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00808-5     Document Type: Article

References (36)

1. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study
2. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients
3. Meta-analysis of branched-chain amino acids in hepatic encephalopathy
4. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis
5. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study
6. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis
7. The cerebral and peripheral uptake of ammonia in liver disease with a hypothesis for the mechanism of hepatic coma
8. Brain energy metabolism in acute hepatic coma
9. Portal-systemic encephalopathy
10. False adrenergic transmitters
11. Alterations in brain octopamine and brain tyrosine following portacaval anastomosis in rats
12. Neurotransmitters in hepatic encephalopathy
13. Long-term effects of portacaval anastomosis on the 5-hydroxytryptamine, histamine, and catecholamine neurotransmitter systems in rat brain
14. Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy
15. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids
16. Relationship of brain glutamine and brain neutral amino acid concentrations after portacaval anastomosis in rats
17. The role of plasma amino acids in hepatic encephalopathy
18. Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids
19. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma
20. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions
21. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy
22. Opposing effects of prolonged ammonia and branched chain amino acid infusions on the accumulation of aromatic amino acids by brain
23. Infusion of branched-chain amino acids and ammonium salts in rats with portacaval shunts
24. Intra- and extracellular amino acid concentrations in portacaval-shunted rabbits. Role of hyperammonemia and effects of branched-chain amino acid-enriched parenteral nutrition
25. Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma
26. Effect of hyperammonemia on leucine and protein metabolism in rats
27. Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis
28. Regional blood-brain barrier permeability to amino acids after portacaval anastomosis
29. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle
30. Skeletal muscle and whole-body protein turnover in cirrhosis
31. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation
32. Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy
33. Portal-systemic encephalopathy: A disorder of multiple neurotransmitter systems
34. Effects of a peptide mixture with a high Fischer's ratio on serum and cerebral cortex amino acid levels and on cerebral cortex monoamine levels, compared with an amino acid mixture with a high Fischer's ratio
35. Preparation of peptide mixture with high Fischer ratio from protein hydrolysate by adsorption on activated carbon
36. Major liver resection results in a changed plasma amino acid pattern as reflected by a decreased Fischer ratio which improves by bactericidal/permeability increasing protein